Tess June 7th, 2006
By Serena Gordon
HealthDay Reporter
(HealthDay News) — A new review of past studies on the effect that attention-deficit hyperactivity disorder (ADHD) drugs have on children’s growth concludes that the drugs do, in fact, suppress growth to some degree.
While the effect found was statistically significant, one of the study’s authors, Dr. Omar Khwaja, an instructor in neurology at Children’s Hospital Boston, said the average growth suppression for a 10-year-old boy was probably about three-quarters of an inch in height and a little more than two pounds in weight.
Read the rest of this post here (670 words, estimated 2:41 mins reading time)
Tess April 16th, 2006
The Asthma Medication Advair and a related drug will bear stronger warnings of an increased risk of death associated with one of their ingredients.
The revised warnings apply to Advair and Serevent, Food and Drug Administration spokeswoman Laura Alvey said. Advair is GlaxoSmithKline’s best-selling product, and Serevent is another of the British company’s drugs.
The updated versions of the “black-box†warnings on both drugs caution that salmeterol, one of the active ingredients in Advair and the active ingredient in Serevent, may increase the risk of asthma-related death. Black-box warnings are the most severe warnings the FDA can require of prescription drugs.
Read the rest of this post here (492 words, estimated 1:58 mins reading time)
Tess April 8th, 2006
(HealthDay News) — Children’s behavior and sleep improved after they had a tonsillectomy, whether or not they had sleep apnea before the surgery, according to a University of Michigan Health System study.
And among children in the study who had attention deficit hyperactivity disorder (ADHD) before the surgery, about half did not have it a year after their tonsils were removed.
Read the rest of this post here (262 words, estimated 1:03 mins reading time)
